XML 214 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - EUR (€)
€ in Millions
Total
Issued and Outstanding Shares
Share Premium
Treasury Shares at Cost
Retained Earnings
OCI
 [1]
Beginning Balance (in shares) at Dec. 31, 2019   419,800,000        
Beginning Balance at Dec. 31, 2019 € 12,592.2 € 38.2 € 3,772.0 € (1,019.6) € 9,523.8 € 277.8
Components of comprehensive income:            
Net income 3,553.7       3,553.7  
Proportionate share of OCI from equity method investments (1.3)         (1.3)
Gain (loss) on foreign currency translation (73.8)         (73.8)
Gain (loss) on financial instruments (23.3)         (23.3)
Total comprehensive income 3,455.3       3,553.7 (98.4)
Purchase of treasury shares (in shares)   (3,900,000)        
Purchase of treasury shares (1,207.5) € 0.0   (1,207.5)    
Cancellation of treasury shares 0.0 € 0.7   1,262.3 (1,261.6)  
Share-based payments 53.9   53.9      
Issuance of shares (in shares)   600,000        
Issuance of shares 37.9 € 0.1 (45.8) 101.6 (18.0)  
Dividend paid € (1,066.4)       (1,066.4)  
Ending Balance (in shares) at Dec. 31, 2020 416,514,034 416,500,000        
Ending Balance at Dec. 31, 2020 € 13,865.4 € 37.6 3,780.1 (863.2) 10,731.5 179.4
Components of comprehensive income:            
Net income 5,883.2       5,883.2  
Proportionate share of OCI from equity method investments 22.0         22.0
Gain (loss) on foreign currency translation 93.3         93.3
Gain (loss) on financial instruments 38.8         38.8
Total comprehensive income € 6,037.3       5,883.2 154.1
Purchase of treasury shares (in shares) (14,358,838) (14,400,000)        
Purchase of treasury shares € (8,560.3)     (8,560.3)    
Cancellation of treasury shares 0.0 € 1.2   6,926.6 6,925.4  
Share-based payments 117.5   117.5      
Issuance of shares (in shares)   500,000        
Issuance of shares 49.0 € 0.1 (21.5) 74.1 (3.7)  
Dividend paid € (1,368.3)       (1,368.3)  
Ending Balance (in shares) at Dec. 31, 2021 402,601,613 402,600,000        
Ending Balance at Dec. 31, 2021 € 10,140.6 € 36.5 3,876.1 (2,422.8) 8,317.3 333.5
Components of comprehensive income:            
Net income 5,624.2       5,624.2  
Proportionate share of OCI from equity method investments 37.7         37.7
Gain (loss) on foreign currency translation 66.0         66.0
Gain (loss) on financial instruments (8.9)         (8.9)
Total comprehensive income € 5,719.0       5,624.2 94.8
Purchase of treasury shares (in shares) (8,538,787) (8,500,000)        
Purchase of treasury shares € (4,639.7)     (4,639.7)    
Cancellation of treasury shares 0.0 € 0.3   2,333.7 2,333.4  
Share-based payments 68.9   68.9      
Issuance of shares (in shares)   500,000        
Issuance of shares 81.8 € 0.1 (4.2) 87.5 (1.6)  
Dividend paid € (2,559.8)       (2,559.8)  
Ending Balance (in shares) at Dec. 31, 2022 394,589,411 394,600,000        
Ending Balance at Dec. 31, 2022 € 8,810.8   € 3,940.8 € (4,641.3) € 9,046.7 € 428.3
[1] As of December 31, 2022, accumulated OCI consists of €32.8 million gain relating to our proportionate share of other comprehensive income from equity method investments (2021: €4.9 million loss; 2020: €26.9 million loss), €387.9 million relating to foreign currency translation gain (2021: €321.9 million gain; 2020: €228.6 million gain) and €7.6 million relating to unrealized gains on financial instruments (2021: €16.5 million gains; 2020: €22.3 million losses).